Retatrutide (LY3437943) is a novel triple GLP-1/GIP/glucagon receptor agonist currently in Phase 3 clinical trials. As research interest has grown following striking Phase 2 weight loss data, many laboratories and research institutions have begun seeking verified sources of retatrutide for preclinical research. This guide covers what to look for when sourcing retatrutide for legitimate research applications.
Why Source Quality Matters for Retatrutide Research
Retatrutide is a complex 32-amino acid peptide with a fatty acid chain modification that enables its extended half-life. Synthesis quality, sequence accuracy, and acylation fidelity are critical to ensuring that research results reflect the compound’s actual pharmacological profile. Impure or incorrectly synthesized material will produce confounded or irreproducible results.
Unlike simple peptides, retatrutide’s activity depends not only on sequence accuracy but on the structural integrity of its acyl chain. Low-grade synthesis may yield partially acylated or truncated sequences that have different receptor binding profiles than the intended compound.
Free Tool
Peptide Reconstitution Calculator
Convert vial strength, water volume, and desired dose into precise syringe units. Works for BPC-157, TB-500, GHK-Cu, and all research peptides.
Try the Calculator →What to Look for in a Retatrutide Research Supplier
When evaluating a retatrutide supplier for research purposes, the following standards should be met:
1. Third-Party HPLC Testing
High-performance liquid chromatography (HPLC) is the standard method for verifying peptide purity. A legitimate supplier should provide HPLC chromatograms showing ≥98% purity — ideally ≥99% — from an independent laboratory, not an in-house test. The certificate of analysis should include a chromatogram with retention time, peak area, and purity percentage.
2. Mass Spectrometry Confirmation
Mass spectrometry (MS) verifies that the molecular weight of the peptide matches the expected molecular weight of retatrutide. This confirms sequence accuracy and the presence of the acyl modification. Both HPLC and MS data should be available in the COA.
3. Batch-Specific COA
Each vial should correspond to a specific batch with its own COA. Generic COAs that aren’t tied to a specific lot number are a red flag — they may represent testing from a single batch applied across multiple different batches, or they may be fabricated.
4. Transparent Sourcing and Manufacturing Information
Reputable suppliers are transparent about their synthesis partners and can provide information about manufacturing standards. GMP-adjacent synthesis practices, though not always available for research-grade peptides, indicate a higher level of quality control.
Red Flags When Sourcing Retatrutide
Researchers should be cautious of suppliers that offer pricing significantly below market rates for high-purity material (complex acylated peptides have higher synthesis costs), do not provide third-party COAs or provide identical COAs across multiple products, cannot be contacted for technical questions or do not have verifiable business information, have no track record or verifiable reviews from the research community, or offer vague storage instructions or provide product that appears discolored or improperly lyophilized.
Retatrutide Storage and Reconstitution
Lyophilized retatrutide should be stored at −20°C for long-term stability. Once reconstituted with bacteriostatic water, it should be stored at 2–8°C and used within 28–30 days. Retatrutide’s acyl chain makes it somewhat more prone to aggregation in solution compared to non-acylated peptides — researchers should gently roll the vial rather than vortexing during reconstitution.
Sourcing Retatrutide from Prax Peptides
Prax Peptides offers retatrutide for research purposes with independently verified purity of ≥99% by HPLC and mass spectrometry confirmation. Each batch comes with a full COA that includes the chromatogram, molecular weight confirmation, and lot-specific results. Prax Peptides provides batch-specific testing — not generic or reused COAs — ensuring that researchers can have confidence in the quality of every vial.
For research programs evaluating retatrutide’s triple agonist mechanism, the peptide is available in standard vial sizes optimized for preclinical research applications. Browse the full research peptide catalog at Prax Peptides for additional GLP-1 class peptides and complementary research compounds.
⚠️ Research Use Only: All compounds referenced on this site are intended strictly for laboratory research purposes. They are not approved for human use or consumption by the FDA or any regulatory authority. This content is for informational purposes only and does not constitute medical advice.